Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 18701-18750 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT02886585
Pembrolizumab In Central Nervous System Metastases
PHASE2Active, not recruiting
101 participants
Started: Oct 31, 2016 · Completed: Dec 31, 2027
1 condition2 sponsors2 locations
NCT02251665
National Cerebral and Cardiovascular Center (NCVC) Stroke Registry
N/AActive, not recruiting
5,374 participants
Started: Oct 31, 2016 · Completed: Mar 31, 2028
1 condition1 sponsor1 location
NCT02965950
The p53 Breast Cancer Trial
PHASE2Active, not recruiting
190 participants
Started: Oct 31, 2016 · Completed: May 31, 2033
2 conditions1 sponsor5 locations
NCT02951598
A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)
N/AActive, not recruiting
1,400 participants
Started: Oct 29, 2016 · Completed: Apr 28, 2026
2 conditions1 sponsor77 locations
NCT02951052
Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults
PHASE3Active, not recruiting
618 participants
Started: Oct 28, 2016 · Completed: Dec 31, 2025
2 conditions3 sponsors113 locations
NCT02938520
Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants
PHASE3Active, not recruiting
631 participants
Started: Oct 27, 2016 · Completed: Dec 31, 2025
1 condition3 sponsors108 locations
NCT02835287
Diabetes Complication Control in Community Clinics (D4C) Trial
NAActive, not recruiting
11,132 participants
Started: Oct 26, 2016 · Completed: Dec 31, 2023
4 conditions2 sponsors2 locations
NCT02791880
Acute Kidney Injury Genomics and Biomarkers in TAVR Study
N/AActive, not recruiting
62 participants
Started: Oct 25, 2016 · Completed: Mar 31, 2031
6 conditions1 sponsor3 locations
NCT02485730
Early Identification of Markers in Alzheimer's Families / ALFA
N/AActive, not recruiting
419 participants
Started: Oct 25, 2016 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT02738866
Palbociclib With Fulvestrant for Metastatic Breast Cancer After Treatment With Palbociclib and an Aromatase Inhibitor
PHASE2Active, not recruiting
60 participants
Started: Oct 25, 2016 · Completed: Dec 31, 2025
1 condition2 sponsors5 locations
NCT02970747
Non-interventional Study of Kyprolis® in Combination With Revlimid® and Dexamethasone or Dexamethasone Alone or in Combination With Darzalex® and Dexamethasone in Multiple Myeloma Patients
N/AActive, not recruiting
359 participants
Started: Oct 25, 2016 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT02945800
Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma
PHASE2Active, not recruiting
59 participants
Started: Oct 25, 2016 · Completed: Feb 28, 2026
4 conditions2 sponsors14 locations
NCT03490656
Assessment of Investigational Magnetic Resonance Imaging and Post-Processing Procedures
NAActive, not recruiting
77 participants
Started: Oct 21, 2016 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT03889119
Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer
NAActive, not recruiting
100 participants
Started: Oct 21, 2016 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03979924
Mouth Opening, Prevention, Education, Nutrition (OPEN)
NAActive, not recruiting
175 participants
Started: Oct 20, 2016 · Completed: Sep 30, 2026
2 conditions1 sponsor6 locations
NCT02967848
Liver Function Investigation With SPECT
N/AActive, not recruiting
20 participants
Started: Oct 19, 2016 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT02490904
Eplerenone in Patients Undergoing REnal Transplant (EPURE TRANSPLANT)
PHASE3Active, not recruiting
132 participants
Started: Oct 19, 2016 · Completed: Aug 31, 2031
1 condition1 sponsor7 locations
NCT02907398
Adherence and Outcome of Upper Airway Stimulation (UAS) for OSA International Registry
N/AActive, not recruiting
5,000 participants
Started: Oct 19, 2016 · Completed: Dec 31, 2025
1 condition1 sponsor64 locations
NCT02774759
Feasibility of the NEXT Steps Weight Loss Intervention +/- Resistance Training for Endometrial Cancer Survivors: Effect on Lean Mass & Biomarkers
NAActive, not recruiting
15 participants
Started: Oct 17, 2016 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT02933736
Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients
EARLY_PHASE1Active, not recruiting
48 participants
Started: Oct 17, 2016 · Completed: Mar 31, 2026
2 conditions4 sponsors1 location
NCT02817958
Evaluation of Lymphadenectomy and Chemotherapy TIP on Inguinal Lymph Nodes in Squamous Cell Carcinoma of the Penis
PHASE2Active, not recruiting
37 participants
Started: Oct 17, 2016 · Completed: Sep 30, 2028
2 conditions2 sponsors17 locations
NCT02914496
ACT Stress Management in Type 1 Diabetes
NAActive, not recruiting
81 participants
Started: Oct 15, 2016 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT02773030
A Study to Determine Dose, Safety, Tolerability, Drug Levels, and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Participants With Multiple Myeloma
PHASE1/PHASE2Active, not recruiting
466 participants
Started: Oct 14, 2016 · Completed: Feb 6, 2028
1 condition1 sponsor89 locations
NCT02676349
Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)
PHASE2Active, not recruiting
130 participants
Started: Oct 13, 2016 · Completed: Oct 31, 2027
1 condition1 sponsor26 locations
NCT02811861
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
PHASE3Active, not recruiting
1,069 participants
Started: Oct 13, 2016 · Completed: Mar 31, 2026
1 condition2 sponsors183 locations
NCT02936505
Clinical Study Evaluating Two Treatment Protocols for Immunosuppressive Drugs. Looking at 3-year Incidence of CLAD.
NAActive, not recruiting
249 participants
Started: Oct 12, 2016 · Completed: Oct 30, 2026
2 conditions5 sponsors5 locations
NCT02800460
New Approaches in MRI at 3T Dedicated to Targeting Subthalamic Nucleus on Parkinsonian Patients
NAActive, not recruiting
35 participants
Started: Oct 12, 2016 · Completed: Dec 7, 2025
1 condition1 sponsor1 location
NCT03327714
Mindfulness as a Method of Improving the Well-being, Quality of Life and Health of Primary School Pupils
NAActive, not recruiting
1,750 participants
Started: Oct 12, 2016 · Completed: Jun 30, 2039
2 conditions2 sponsors1 location
NCT02443077
Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
PHASE3Active, not recruiting
94 participants
Started: Oct 12, 2016 · Completed: Dec 24, 2025
2 conditions1 sponsor282 locations
NCT02789228
Research Study Utilizing Expanded Multi-antigen Specific Lymphocytes for the Treatment of Solid Tumors
PHASE1Active, not recruiting
28 participants
Started: Oct 12, 2016 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05729945
Catholic Health Initiatives (CHI) St. Joseph's Children Home Visiting Longitudinal Study
NAActive, not recruiting
343 participants
Started: Oct 11, 2016 · Completed: Dec 5, 2038
7 conditions1 sponsor1 location
NCT02669173
Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma
PHASE1Active, not recruiting
12 participants
Started: Oct 11, 2016 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT02876107
Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer
PHASE2Active, not recruiting
42 participants
Started: Oct 6, 2016 · Completed: Oct 31, 2027
11 conditions3 sponsors1 location
NCT02468895
MYOPROSP - a Prospective Cohort Study in Myositis
N/AActive, not recruiting
300 participants
Started: Oct 4, 2016 · Completed: Dec 31, 2030
2 conditions15 sponsors1 location
NCT02923570
Study of Proton Versus Photon Beam Radiotherapy in the Treatment of Head and Neck Cancer
PHASE2Active, not recruiting
108 participants
Started: Oct 3, 2016 · Completed: Oct 31, 2025
1 condition2 sponsors9 locations
NCT02914873
SPCG17: Prostate Cancer Active Surveillance Trigger Trial
NAActive, not recruiting
2,000 participants
Started: Oct 3, 2016 · Completed: Dec 31, 2034
1 condition1 sponsor23 locations
NCT06422130
Ningbo Maternity-Child Linked Database Study
N/AActive, not recruiting
325,596 participants
Started: Oct 1, 2016 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT03076008
The Impact of Tibial Tubercle-trochlear Groove Distance and Patellar Height on the Outcome of Isolated Medial Patellofemoral Ligament Reconstruction
N/AActive, not recruiting
201 participants
Started: Oct 1, 2016 · Completed: Dec 31, 2025
1 condition4 sponsors1 location
NCT02694185
Secondary Event Prevention Using Population Risk Management After PCI and for Anti-Rheumatic Medications
NAActive, not recruiting
5,269 participants
Started: Oct 1, 2016 · Completed: Feb 28, 2025
2 conditions1 sponsor5 locations
NCT03152422
Urinary Proteomics in Predicting Heart Transplantation Outcomes
N/AActive, not recruiting
352 participants
Started: Oct 1, 2016 · Completed: Dec 31, 2025
1 condition1 sponsor0 locations
NCT02799160
Clinical, Biochemical and Haemodynamic Effects of Large-volume Paracentesis (LVP) in Inflammatory Situations
N/AActive, not recruiting
22 participants
Started: Oct 1, 2016 · Completed: Jun 1, 2024
1 condition3 sponsors1 location
NCT02896452
Astronaut Vision Issues in a Ground Analog Population: Polycystic Ovary Syndrome
N/AActive, not recruiting
60 participants
Started: Oct 1, 2016 · Completed: Sep 30, 2026
2 conditions6 sponsors1 location
NCT02842203
Use of ctDNA for Monitoring of Stage III Colorectal Cancer
N/AActive, not recruiting
137 participants
Started: Sep 30, 2016 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT02889458
Hong Kong Breast Cancer Study
N/AActive, not recruiting
7,000 participants
Started: Sep 30, 2016 · Completed: Dec 31, 2028
2 conditions2 sponsors21 locations
NCT02924701
sCD163 in PBC Patients - Assessment of Disease Severity and Prognosis
N/AActive, not recruiting
168 participants
Started: Sep 30, 2016 · Completed: Sep 30, 2031
2 conditions1 sponsor1 location
NCT02891954
Genetics of Response to Canagliflozin
PHASE1Active, not recruiting
700 participants
Started: Sep 30, 2016 · Completed: Sep 25, 2025
1 condition2 sponsors0 locations
NCT02778685
Pembrolizumab, Endocrine Therapy, and Palbociclib in Treating Postmenopausal Patients With Newly Diagnosed Metastatic Stage IV Estrogen Receptor Positive Breast Cancer
PHASE2Active, not recruiting
47 participants
Started: Sep 30, 2016 · Completed: Mar 30, 2026
2 conditions2 sponsors7 locations
NCT02917720
2nd or 3rd TKI-stop After 2 Years Nilotinib Pre-treatment in CML-patients
PHASE2Active, not recruiting
75 participants
Started: Sep 30, 2016 · Completed: Sep 30, 2027
1 condition3 sponsors15 locations
NCT02914912
Investigation of Chronic Intestinal Ischemia
N/AActive, not recruiting
100 participants
Started: Sep 30, 2016 · Completed: Jan 31, 2025
1 condition1 sponsor2 locations
NCT02772770
Pediatric ACL: Understanding Treatment Options
N/AActive, not recruiting
765 participants
Started: Sep 30, 2016 · Completed: Dec 31, 2030
1 condition10 sponsors10 locations